RVL Pharmaceuticals PLC (RVLPQ)
0.00
USD |
OTCM |
Apr 26, 16:00
RVL Pharmaceuticals Total Liabilities (Quarterly): 69.08M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 69.08M |
| March 31, 2023 | 71.11M |
| December 31, 2022 | 77.42M |
| September 30, 2022 | 86.81M |
| June 30, 2022 | 66.32M |
| March 31, 2022 | 74.82M |
| December 31, 2021 | 67.94M |
| September 30, 2021 | 54.80M |
| June 30, 2021 | 266.56M |
| March 31, 2021 | 269.97M |
| December 31, 2020 | 277.09M |
| Date | Value |
|---|---|
| September 30, 2020 | 276.56M |
| June 30, 2020 | 331.79M |
| March 31, 2020 | 331.39M |
| December 31, 2019 | 348.55M |
| September 30, 2019 | 352.48M |
| June 30, 2019 | 385.92M |
| March 31, 2019 | 394.91M |
| December 31, 2018 | 411.78M |
| September 30, 2018 | 439.97M |
| June 30, 2018 | 438.71M |
| December 31, 2017 | 483.96M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
54.80M
Minimum
Sep 2021
385.92M
Maximum
Jun 2019
200.51M
Average
266.56M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 85.40M |
| Shareholders Equity (Quarterly) | 16.33M |
| Debt to Equity Ratio | 3.537 |
| Current Ratio | 0.3765 |
| Net Debt Paydown Yield | -4.00% |